New drug hopes to calm lupus skin flares
NCT ID NCT07260877
First seen Jan 08, 2026 · Last updated Apr 30, 2026 · Updated 11 times
Summary
This study tests an experimental drug called VENT-03 in 24 adults with active lupus skin disease (cutaneous lupus), with or without systemic lupus. For the first 4 weeks, some get the drug and some get a placebo; then everyone gets VENT-03 for 8 more weeks. The goal is to see if VENT-03 reduces skin inflammation and is safe.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Investigative Site
RECRUITINGBeverly Hills, California, 90211, United States
-
Investigative Site
RECRUITINGClearwater, Florida, 33765, United States
-
Investigative Site
RECRUITINGDeBary, Florida, 32713, United States
-
Investigative Site
RECRUITINGTampa, Florida, 33606, United States
-
Investigative Site
RECRUITINGSaint Joseph, Missouri, 64506, United States
-
Investigative Site
RECRUITINGFairport, New York, 14450, United States
-
Investigative Site
RECRUITINGMemphis, Tennessee, 38119, United States
-
Investigative Site
RECRUITINGAllen, Texas, 75013, United States
-
Investigative Site
RECRUITINGArlington, Texas, 76012, United States
-
Investigative Site
RECRUITINGColleyville, Texas, 76034, United States
-
Investigative Site
RECRUITINGHaskovo, Bulgaria
-
Investigative Site
RECRUITINGPlovdiv, Bulgaria
-
Investigative Site
RECRUITINGSofia, Bulgaria
-
Investigative Site
RECRUITINGParis, France
-
Investigative Site
RECRUITINGToulouse, France
-
Investigative Site
RECRUITINGTbilisi, Georgia
-
Investigative Site
RECRUITINGSzeged, Hungary
-
Investigative Site
RECRUITINGBialystok, Poland
-
Investigative Site
RECRUITINGOświęcim, Poland
-
Investigative Site
RECRUITINGPoznan, Poland
-
Investigative Site
RECRUITINGRzeszów, Poland
-
Investigative Site
RECRUITINGŚląskie, Poland
-
Investigative Site
RECRUITINGWarsaw, Poland
-
Investigative Site
RECRUITINGWroclaw, Poland
-
Investigative Site
RECRUITINGPretoria, South Africa
-
Investigative Site
RECRUITINGStellenbosch, South Africa
-
Investigative Site
RECRUITINGBadajoz, Spain
Conditions
Explore the condition pages connected to this study.